Company Profile
Eagle Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- EGRX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.05 USD (-0.39%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, EGRX closed down 0.39% at $0.0508. No new same-company headline was identified in the current news window.
Company overview
Business overview
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products. Its business has historically centered on commercialization of focused injectable or hospital-based medicines.
Geographic Base and Sector Classification
Eagle is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and hospital care.
Business Model Characteristics
The company depends on product sales, hospital access, and portfolio management. Investors usually watch revenue, execution, and strategic changes.
Position Within the Biotechnology Landscape
Eagle occupies a hospital-specialty niche within pharma. It is more commercial than development-stage biotech and tends to respond to product and portfolio developments.
Future catalysts
Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path. The market cares about recurring demand and margin discipline.
Recent news
- 01
Eagle Pharmaceuticals Announces Divestiture of Barhemsys
Source: Eagle Pharmaceuticals
- 02
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
Source: Eagle Pharmaceuticals
- 03
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
Source: Eagle Pharmaceuticals
- 04
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
Source: Eagle Pharmaceuticals
- 05
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
Source: Eagle Pharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Eagle Pharmaceuticals (EGRX)?
Eagle Pharmaceuticals (EGRX) most recently closed at 0.05 USD, a -0.39% move versus the previous session.
What does Eagle Pharmaceuticals do?
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products. Its business has historically centered on commercialization of focused injectable or hospital-based medicines.
On which exchange is EGRX stock listed?
Eagle Pharmaceuticals (EGRX) is associated with NASDAQ, United States, Biopharma.
What is Eagle?
Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path.
Which conditions is Eagle Pharmaceuticals targeting with Eagle?
Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path.
How does Eagle Pharmaceuticals describe recent progress with Eagle?
Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path.
What is Pharmaceuticals?
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products.
What should investors watch for with Pharmaceuticals?
Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path. The market cares about recurring demand and margin discipline.